+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ophthalmic Drug Delivery System Market by Drug Type, Delivery Device Type, Product Type, Formulation Type, Mode Of Delivery, Application, End User - Global Forecast 2025-2030- Product Image
Ophthalmic Drug Delivery System Market by Drug Type, Delivery Device Type, Product Type, Formulation Type, Mode Of Delivery, Application, End User - Global Forecast 2025-2030- Product Image
Sale

Ophthalmic Drug Delivery System Market by Drug Type, Delivery Device Type, Product Type, Formulation Type, Mode Of Delivery, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715781
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The ophthalmic drug delivery system market is undergoing rapid transformation, driven by technological advancement, regulatory shifts, and changing patient needs. Senior leaders evaluating growth strategies or portfolio alignment can leverage this analysis to navigate a complex environment where innovation and compliance determine long-term competitive advantage.

Market Snapshot: Ophthalmic Drug Delivery System Market Size & Growth

The Ophthalmic Drug Delivery System Market grew from USD 15.50 billion in 2024 to USD 16.84 billion in 2025. It is expected to continue growing at a CAGR of 8.84%, reaching USD 25.79 billion by 2030. Robust growth reflects both maturing and emerging segments, with innovation accelerating adoption across chronic and acute ocular conditions. The market’s diversified technology base, supported by robust demand for advanced therapies, signals strong industry engagement from development through to commercialization.

Scope & Segmentation: Navigating Market Complexity

  • Drug Types: Anti-Allergy, Anti-Glaucoma, Anti-Infective, Anti-Inflammatory, Anti-VEGF. Each type addresses distinct clinical conditions, with innovations expanding application breadth.
  • Delivery Device Types: Contact Lens Drug Delivery, Intraocular Implants, Microneedles, Ocular Inserts, Ophthalmic Sprays, Topical Gels. Devices are increasingly engineered for site-specific dosing and enhanced retention.
  • Product Types: Over-The-Counter Drug Formulations, Prescription Drug Formulations (Controlled-Release Formulations, Standard Formulations). This reflects differing regulatory and access pathways.
  • Formulation Types: Liquid Formulations, Semi-Solid Formulations (Creams, Gels, Ointments), Solid Formulations (Capsules, Tablets). Format choice impacts bioavailability and dosing convenience.
  • Modes Of Delivery: Intraocular, Intravitreal, Periocular, Systemic, Topical. Route selection optimizes therapy for various anatomical and pathological requirements.
  • Applications: Allergy Treatment, Dry Eye Syndrome, Glaucoma, Ocular Infections, Retinal Disorders, Surgical Recovery. Solutions are tailored to diverse ocular health demands.
  • End Users: Hospitals, Ophthalmic Clinics, Research Organizations. Each stakeholder has unique purchasing drivers and validation requirements.
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Gulf Cooperation Council states, South Africa, Turkey), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia). Regional disparities shape market strategies and product positioning.
  • Key Companies: Includes Abbott Laboratories, AbbVie Inc., Alcon Vision LLC, Bausch Health, Carl Zeiss AG, EyePoint Pharmaceuticals, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and others. Leaders are advancing through R&D integration, partnerships, and regulatory expertise.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Multi-disciplinary collaboration among scientists, engineers, and clinicians accelerates targeted drug delivery solutions, improving therapeutic outcomes.
  • Advancements in biocompatible polymers and microfabrication support next-generation devices, such as microneedle arrays and sustained-release implants, catering to personalized patient care models.
  • Digital tools, including wearable sensors, are beginning to merge with delivery devices, enabling real-time therapy monitoring and data-driven dosing optimization.
  • Adaptable regulatory pathways are streamlining approvals, prompting earlier market entry for innovative combination products and therapies.
  • Eco-friendly materials and packaging solutions gain traction as environmental accountability becomes integral to brand differentiation and regulatory compliance.
  • Strategic alliances—between pharmaceutical and medical device firms, as well as academic-industry consortia—expand access to new markets and speed up commercial readiness for emerging therapies.

Tariff Impact: Supply Chain and Pricing Considerations

Recent U.S. tariffs on pharmaceutical ingredients and medical devices have imposed cost pressures on raw materials and components. These tariff-related increases prompt supply chain reassessment, leading manufacturers to diversify suppliers and strengthen domestic procurement. Downstream effects include pricing adjustments for ocular therapies, impacting patient access and raising concerns about affordability in markets with limited reimbursement. Enterprises with lean manufacturing and localized sourcing demonstrate greater resilience in the face of such external shocks.

Ophthalmic Drug Delivery System Market: Methodology & Data Sources

This market research synthesizes extensive secondary and primary data. Published literature, regulatory filings, and company reports were complemented by interviews with executives and clinical leaders across major geographies. Triangulation and rigorous validation ensured data accuracy, while analytic frameworks clarified competitive dynamics and segmentation trends.

Why This Report Matters: Actionable Value for Decision-Makers

  • Delivers critical insights to support investment, R&D prioritization, and supply chain optimization in a rapidly evolving market.
  • Highlights emerging technologies and regulatory strategies essential for maintaining a strong portfolio and meeting evolving patient demands.
  • Equips executives to assess region-specific opportunities and risks, aligning commercial efforts with unmet clinical needs and payer expectations.

Conclusion

The ophthalmic drug delivery system market presents significant opportunities and challenges for organizations seeking growth and differentiation. A strategic, data-driven approach ensures leadership amid ongoing innovation and evolving patient care standards.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rise of biodegradable intravitreal implants offering sustained drug release for wet AMD patients
5.2. Integration of microneedle-based ocular patches for minimally invasive therapy delivery in chronic eye conditions
5.3. Adoption of novel nanocarrier formulations for enhanced corneal penetration and bioavailability
5.4. Expansion of gene therapy approaches using viral vectors for inherited retinal disease treatment
5.5. Growth of patient-friendly in situ gelling eye drops enabling prolonged drug retention on ocular surface
5.6. Use of contact lenses embedded with drug reservoirs for controlled glaucoma medication release
5.7. Partnerships between biotech firms and ophthalmic device manufacturers to co-develop combination drug-device products
5.8. Implementation of artificial intelligence predictive models to optimize personalized dosing in ophthalmic drug administration
5.9. Emergence of 3D printed ocular implants tailored to individual patient anatomy for targeted drug delivery
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Ophthalmic Drug Delivery System Market, by Drug Type
8.1. Introduction
8.2. Anti-Allergy
8.3. Anti-Glaucoma
8.4. Anti-Infective
8.5. Anti-Inflammatory
8.6. Anti-VEGF
9. Ophthalmic Drug Delivery System Market, by Delivery Device Type
9.1. Introduction
9.2. Contact Lens Drug Delivery
9.3. Intraocular Implants
9.4. Microneedles
9.5. Ocular Inserts
9.6. Ophthalmic Sprays
9.7. Topical Gels
10. Ophthalmic Drug Delivery System Market, by Product Type
10.1. Introduction
10.2. Over-The-Counter Drug Formulations
10.3. Prescription Drug Formulations
10.3.1. Controlled-Release Formulations
10.3.2. Standard Formulations
11. Ophthalmic Drug Delivery System Market, by Formulation Type
11.1. Introduction
11.2. Liquid Formulations
11.3. Semi-Solid Formulations
11.3.1. Creams
11.3.2. Gels
11.3.3. Ointments
11.4. Solid Formulations
11.4.1. Capsules
11.4.2. Tablets
12. Ophthalmic Drug Delivery System Market, by Mode Of Delivery
12.1. Introduction
12.2. Intraocular
12.3. Intravitreal
12.4. Periocular
12.5. Systemic
12.6. Topical
13. Ophthalmic Drug Delivery System Market, by Application
13.1. Introduction
13.2. Allergy Treatment
13.3. Dry Eye Syndrome
13.4. Glaucoma
13.5. Ocular Infections
13.6. Retinal Disorders
13.7. Surgical Recovery
14. Ophthalmic Drug Delivery System Market, by End User
14.1. Introduction
14.2. Hospitals
14.3. Ophthalmic Clinics
14.4. Research Organizations
15. Americas Ophthalmic Drug Delivery System Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Ophthalmic Drug Delivery System Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Ophthalmic Drug Delivery System Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Abbott Laboratories
18.3.2. AbbVie Inc.
18.3.3. Alcon Vision LLC
18.3.4. Apotex Inc.
18.3.5. AptarGroup, Inc.
18.3.6. Bausch Health Companies Inc.
18.3.7. Bayer AG
18.3.8. Carl Zeiss AG
18.3.9. DifGen Pharmaceuticals LLC
18.3.10. EyePoint Pharmaceuticals, Inc.
18.3.11. F. Hoffmann-La Roche AG
18.3.12. Genentech, Inc.
18.3.13. Gerresheimer AG
18.3.14. Iskon Remedies
18.3.15. Johnson & Johnson Service, Inc.
18.3.16. Mati Therapeutics, Inc.
18.3.17. Merck KGaA
18.3.18. MgShell S.R.L.
18.3.19. Nicox SA
18.3.20. Novartis AG
18.3.21. Ocular Therapeutix Inc.
18.3.22. Oculis SA
18.3.23. Pfizer Inc.
18.3.24. Recipharm AB
18.3.25. Regeneron Pharmaceuticals, Inc.
18.3.26. Santen Pharmaceutical Co., Ltd.
18.3.27. Sun Pharmaceutical Industries, Inc.
18.3.28. Terumo Corporation
18.3.29. Teva Pharmaceutical Industries Ltd.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MODE OF DELIVERY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MODE OF DELIVERY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET: RESEARCHAI
FIGURE 30. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET: RESEARCHSTATISTICS
FIGURE 31. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET: RESEARCHCONTACTS
FIGURE 32. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ANTI-ALLERGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ANTI-ALLERGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ANTI-GLAUCOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ANTI-GLAUCOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ANTI-INFECTIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ANTI-INFECTIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ANTI-VEGF, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ANTI-VEGF, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY CONTACT LENS DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY CONTACT LENS DRUG DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAOCULAR IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAOCULAR IMPLANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRONEEDLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRONEEDLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY OCULAR INSERTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY OCULAR INSERTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY OPHTHALMIC SPRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY OPHTHALMIC SPRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TOPICAL GELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TOPICAL GELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY OVER-THE-COUNTER DRUG FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY OVER-THE-COUNTER DRUG FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRESCRIPTION DRUG FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRESCRIPTION DRUG FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY CONTROLLED-RELEASE FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY CONTROLLED-RELEASE FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY STANDARD FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY STANDARD FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRESCRIPTION DRUG FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRESCRIPTION DRUG FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SEMI-SOLID FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SEMI-SOLID FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY CREAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY CREAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY GELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY GELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY OINTMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SOLID FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SOLID FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MODE OF DELIVERY, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAOCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAOCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAVITREAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAVITREAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PERIOCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PERIOCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SYSTEMIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SYSTEMIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ALLERGY TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ALLERGY TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DRY EYE SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DRY EYE SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY GLAUCOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY GLAUCOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY OCULAR INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY OCULAR INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY RETINAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY RETINAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SURGICAL RECOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SURGICAL RECOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRESCRIPTION DRUG FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRESCRIPTION DRUG FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MODE OF DELIVERY, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRESCRIPTION DRUG FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRESCRIPTION DRUG FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MODE OF DELIVERY, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 147. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 148. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 149. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 150. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 151. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRESCRIPTION DRUG FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 154. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRESCRIPTION DRUG FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 155. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 156. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 157. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 158. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 159. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 160. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 161. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
TABLE 162. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MODE OF DELIVERY, 2025-2030 (USD MILLION)
TABLE 163. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 168. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 169. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 170. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 171. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 172. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 173. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRESCRIPTION DRUG FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 174. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRESCRIPTION DRUG FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 175. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 176. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 177. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 178. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 179. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 180. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 181. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
TABLE 182. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MODE OF DELIVERY, 2025-2030 (USD MILLION)
TABLE 183. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRESCRIPTION DRUG FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRESCRIPTION DRUG FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MODE OF DELIVERY, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRESCRIPTION DRUG FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRESCRIPTION DRUG FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MODE OF DELIVERY, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRESCRIPTION DRUG FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRESCRIPTION DRUG FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MODE OF DELIVERY, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRESCRIPTION DRUG FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRESCRIPTION DRUG FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MODE OF DELIVERY, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 270. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 271. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 272. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 273. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRESCRIPTION DRUG FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 276. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRESCRIPTION DRUG FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 277. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 278. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 279. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 280. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 281. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SOLID FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 282. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY SOLID FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 283. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
TABLE 284. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MODE OF DELIVERY, 2025-2030 (USD MILLION)
TABLE 285. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. FRANCE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 290. FRANCE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 291. FRANCE OPHTHALMIC DRUG DELIVERY SYSTE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Ophthalmic Drug Delivery System market report include:
  • Abbott Laboratories
  • AbbVie Inc.
  • Alcon Vision LLC
  • Apotex Inc.
  • AptarGroup, Inc.
  • Bausch Health Companies Inc.
  • Bayer AG
  • Carl Zeiss AG
  • DifGen Pharmaceuticals LLC
  • EyePoint Pharmaceuticals, Inc.
  • F. Hoffmann-La Roche AG
  • Genentech, Inc.
  • Gerresheimer AG
  • Iskon Remedies
  • Johnson & Johnson Service, Inc.
  • Mati Therapeutics, Inc.
  • Merck KGaA
  • MgShell S.R.L.
  • Nicox SA
  • Novartis AG
  • Ocular Therapeutix Inc.
  • Oculis SA
  • Pfizer Inc.
  • Recipharm AB
  • Regeneron Pharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Sun Pharmaceutical Industries, Inc.
  • Terumo Corporation
  • Teva Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages181
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 16.84 Billion
Forecasted Market Value ( USD ) by 2030 $ 25.79 Billion
Compound Annual Growth Rate8.8%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Ophthalmic Drug Delivery Systems Market Size, Share & Trends Analysis Report By Technology (Eye Drops, Contact Lenses), By Delivery Route, By Production Technology, By Material, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Ophthalmic Drug Delivery Systems Market Size, Share & Trends Analysis Report By Technology (Eye Drops, Contact Lenses), By Delivery Route, By Production Technology, By Material, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 190 Pages
  • Global
From
Hydrogel-based Drug Delivery System Market by Application (Ophthalmic Delivery, Tissue Engineering, Transdermal Delivery), Product Type (Hybrid Polymers, Natural Polymers, Synthetic Polymers), Therapeutic Area, End User - Global Forecast 2025-2030 - Product Image

Hydrogel-based Drug Delivery System Market by Application (Ophthalmic Delivery, Tissue Engineering, Transdermal Delivery), Product Type (Hybrid Polymers, Natural Polymers, Synthetic Polymers), Therapeutic Area, End User - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Nanoparticle Drug Delivery Systems Market by Targeting Technique (Active, Passive), Route of Administration (Intravenous, Ophthalmic, Oral), Application, End User, Particle Type - Global Forecast 2025-2030 - Product Image

Nanoparticle Drug Delivery Systems Market by Targeting Technique (Active, Passive), Route of Administration (Intravenous, Ophthalmic, Oral), Application, End User, Particle Type - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Advanced Drug Delivery Systems - A Global Market Overview - Product Image

Advanced Drug Delivery Systems - A Global Market Overview

  • Report
  • 251 Pages
  • Global
From
Advanced Drug Delivery Systems (ADDS) World Market - Product Image

Advanced Drug Delivery Systems (ADDS) World Market

  • Report
  • 29 Pages
  • Global
From

About the Ophthalmic Drug Delivery System Market

The Ophthalmic Drug Delivery System market is a subset of the larger Drug Delivery market, which focuses on the development and delivery of drugs to the eye. Ophthalmic drug delivery systems are designed to provide targeted delivery of drugs to the eye, with the goal of improving patient outcomes. These systems can be used to deliver a variety of drugs, including antibiotics, anti-inflammatory agents, and anti-glaucoma medications. Ophthalmic drug delivery systems can be divided into two main categories: topical and systemic. Topical delivery systems involve the application of drugs directly to the eye, while systemic delivery systems involve the administration of drugs through the bloodstream. Both types of systems have advantages and disadvantages, and the choice of system depends on the type of drug being delivered and the desired outcome. The Ophthalmic Drug Delivery System market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Alcon, Allergan, Bausch + Lomb, Santen, and Shire. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.